» Articles » PMID: 16288300

Overall Obesity, Abdominal Adiposity, Diabetes and Cigarette Smoking in Relation to the Risk of Pancreatic Cancer in Two Swedish Population-based Cohorts

Overview
Journal Br J Cancer
Specialty Oncology
Date 2005 Nov 17
PMID 16288300
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the associations of body mass index (BMI), waist circumference, a history of diabetes, and cigarette smoking with risk of pancreatic cancer among 37,147 women and 45,906 men followed up during 560,666 person-years in the Swedish Mammography Cohort and the Cohort of Swedish Men; 136 incident cases of pancreatic cancer were diagnosed. The multivariate rate ratio (RR) of pancreatic cancer for obese women and men (BMI > or =30 kg/m(2)) was 1.81 (95% CI: 1.04-3.15) compared to those with a BMI of 20-25 kg/m(2). For a difference of 20 cm (about two standard deviations) in waist circumference, the multivariate RRs were 1.32 (95% CI: 0.73-2.37) among women and 1.74 (95% CI: 1.00-3.01) among men. Pancreatic cancer risk was associated with history of diabetes (multivariate RR: 1.88; 95% CI: 1.09-3.26) and cigarette smoking (multivariate RR for current compared with never smokers: 3.06; 95% CI: 1.99-4.72). Current smokers of > or =40 pack-years had a five-fold elevated risk compared with never smokers. Risk among past smokers approached the RR for never smokers within 5-10 years following smoking cessation. Findings from this prospective study support positive relationships of overall obesity, abdominal adiposity, diabetes and smoking with risk of pancreatic cancer.

Citing Articles

Unraveling the therapeutic potential of phytochemicals to attenuate pancreatic cancer using protein-protein interactions, molecular docking, and MD simulation.

Balkrishna A, Sharma D, Thapliyal M, Arya V, Dabas A In Silico Pharmacol. 2023; 12(1):3.

PMID: 38108042 PMC: 10719185. DOI: 10.1007/s40203-023-00179-9.


Abdominal obesity and digestive system cancer: a systematic review and meta-analysis of prospective studies.

Li X, Lian Y, Ping W, Wang K, Jiang L, Li S BMC Public Health. 2023; 23(1):2343.

PMID: 38012596 PMC: 10680266. DOI: 10.1186/s12889-023-17275-2.


Detection of HHV-6 Virus in specimen of a ductal pancreatic adenocarcinoma with comparison in tumor and normal tissue.

Warkentin S, Braunschweig T, Jonigk D, Losen I, Cassataro M, Kleines M Diagn Pathol. 2023; 18(1):124.

PMID: 37964347 PMC: 10644576. DOI: 10.1186/s13000-023-01402-z.


Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study.

Chan R, Lee T, Chou O, So J, Chung C, Dee E J Endocr Soc. 2022; 6(11):bvac138.

PMID: 36267596 PMC: 9562787. DOI: 10.1210/jendso/bvac138.


Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study.

Gram I, Park S, Wilkens L, Le Marchand L, Setiawan V Cancer Causes Control. 2022; 34(1):89-100.

PMID: 36253659 PMC: 9816198. DOI: 10.1007/s10552-022-01637-z.


References
1.
Gapstur S, Gann P, Lowe W, Liu K, Colangelo L, Dyer A . Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000; 283(19):2552-8. DOI: 10.1001/jama.283.19.2552. View

2.
Fryzek J, Schenk M, Kinnard M, Greenson J, Garabrant D . The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999. Am J Epidemiol. 2005; 162(3):222-8. DOI: 10.1093/aje/kwi183. View

3.
Schneider M, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding X . Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology. 2001; 120(5):1263-70. DOI: 10.1053/gast.2001.23258. View

4.
Berrington de Gonzalez A, Sweetland S, Spencer E . A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer. 2003; 89(3):519-23. PMC: 2394383. DOI: 10.1038/sj.bjc.6601140. View

5.
Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli P, Faivre J . EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol. 2003; 14 Suppl 5:v61-118. DOI: 10.1093/annonc/mdg754. View